Markets Piper cuts Ra Medical to neutral; PT to $1.50 from $9 Piper Jaffray downgraded Ra Medical Systems (NASDAQ:RMED) to “neutral” from “overweight” and slashed its price target to $1.50 from $9 after the company disclosed several operating issues in its preliminary second... August 13, 2019